News
All NewsAAP NewsPNP Corner
Media
Clinical Forum InsightsCure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardProduct ProfileSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Type 1 Diabetes
    • Type 2 Diabetes
  • Gastroenterology
    • Formula
    • Obesity
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
    • Vaccines
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • Nutrition
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement
|Articles|December 1, 2000

Your Voice

Advertisement

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe Now!
Advertisement

Related Content

Advertisement
Arcutis reports positive phase 2 data for roflumilast cream in infants with atopic dermatitis | Image Credit: © triocean - stock.adobe.com.

Arcutis reports positive phase 2 data for roflumilast cream (ZORYVE) in infants with atopic dermatitis

ByMorgan Ebert, Managing Editor
February 2nd 2026
Melatonin use in children calls for caution, experts say | Image Credit: © Svetlana - © Svetlana - stock.adobe.com.

Melatonin use in children calls for caution, experts say

ByCeleste Krewson, Assistant Editor
February 2nd 2026
FDA issues complete response letter for sublingual epinephrine film Anaphylm

FDA issues complete response letter for sublingual epinephrine film Anaphylm

ByMorgan Ebert, Managing Editor
February 2nd 2026
Asma Khalil, PhD, explains how prenatal paracetamol use does not increase developmental risks | Image Credit: stgeorges.nhs.uk.

Asma Khalil, PhD, explains how prenatal paracetamol use does not increase developmental risks

ByAsma Khalil, PhD
February 2nd 2026
Weekly review: Weight gain, cognition, and more

Weekly review: Weight gain, cognition, and more

ByCeleste Krewson, Assistant Editor
February 1st 2026

Latest CME

Burst CME: Targeted Therapy for Optimal Psoriasis Management
Video

Burst CME: Targeted Therapy for Optimal Psoriasis Management

Tina Bhutani, MD

View more
Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management
Video

Cases and Conversations™: A Horizon View of Continuous Monitoring Systems for Diabetes Management

Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP; Anders Carlson, MD; Jennifer B. Green, MD

View more
Advertisement
Advertisement

Trending on Contemporary Pediatrics

1

AAP issues guidance on providing medical care to parents during pediatric visits

2

FDA issues complete response letter for sublingual epinephrine film Anaphylm

3

Low Apgar score, cord pH linked to ADHD risk

4

Weekly review: Weight gain, cognition, and more

5

Asma Khalil, PhD, explains how prenatal paracetamol use does not increase developmental risks

  • About Us
  • Advertise
  • Contact Us
  • Editorial
  • Job Board
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Personal Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us